Type 1 Diabetes Clinical Trial
Official title:
A Pilot Study Examining a Reinforcement Approach to Improve Diabetes Management
Glucose control is necessary to avoid the immediate and long-term adverse effects associated
with type 1 diabetes, and frequent self-monitoring of blood glucose is the first important
step to achieving glucose control. Data suggest that large proportions of adolescents and
young adults fail to adhere to standard guidelines of self-monitored of blood glucose
testing and have hemoglobin A1c levels >7.5%. A finite period of poor metabolic control can
lead to increased risk of medical complications over an individual's lifespan, necessitating
novel interventions to improve self-monitored blood glucose testing and metabolic control in
emerging adults with type 1 diabetes. The investigators treatment approach, which provides
direct tangible reinforcement for objective evidence of behavior change, is efficacious in
decreasing substance use, reducing weight, and improving medication adherence.
The purpose of this project is to develop and pilot test an intervention based on behavioral
economic principles for improving self-monitored blood glucose testing in young persons with
type 1 diabetes. In this pilot study, patients will text in, via cell phones, each time they
test, and a return text will inform them of reinforcer vouchers earned. The investigators
will collect data on self-monitored blood glucose testing frequency and A1c levels preceding
treatment initiation and throughout a 6 month treatment period. If promising, a randomized
trial will lead to larger scale evaluations of reinforcement interventions alone, or in
combination with multimodal treatment approaches, and it may be applied to other clinical
issues such as adherence to continuous glucose monitoring. Importantly, this intervention
can be administered remotely and in an automated fashion, allowing for widespread adoption
if efficacious.
n/a
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05653518 -
Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
|
N/A | |
| Enrolling by invitation |
NCT05515939 -
Evaluating the InPen in Pediatric Type 1 Diabetes
|
||
| Completed |
NCT05109520 -
Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
|
||
| Recruiting |
NCT04016987 -
Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes
|
N/A | |
| Active, not recruiting |
NCT04190368 -
Team Clinic: Virtual Expansion of an Innovative Multi-Disciplinary Care Model for Adolescents and Young Adults With Type 1 Diabetes
|
N/A | |
| Recruiting |
NCT05413005 -
Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus
|
Early Phase 1 | |
| Active, not recruiting |
NCT04668612 -
Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes
|
N/A | |
| Completed |
NCT02837094 -
Enhanced Epidermal Antigen Specific Immunotherapy Trial -1
|
Phase 1 | |
| Recruiting |
NCT05414409 -
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
|
Phase 2 | |
| Recruiting |
NCT05670366 -
The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes
|
N/A | |
| Active, not recruiting |
NCT05418699 -
Real-life Data From Diabetic Patients on Closed-loop Pumps
|
||
| Completed |
NCT04084171 -
Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6
|
N/A | |
| Recruiting |
NCT06144554 -
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
|
||
| Recruiting |
NCT05379686 -
Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes
|
N/A | |
| Recruiting |
NCT05153070 -
Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
|
Phase 2 | |
| Completed |
NCT05281614 -
Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
|
Early Phase 1 | |
| Withdrawn |
NCT04259775 -
Guided User-initiated Insulin Dose Enhancements (GUIDE) to Improve Outcomes for Youth With Type 1 Diabetes
|
N/A | |
| Active, not recruiting |
NCT01600924 -
Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
|
||
| Completed |
NCT02914886 -
Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)
|
Phase 4 | |
| Completed |
NCT02750527 -
Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany
|